AdCLD-CoV19 / Cellid 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AdCLD-CoV19 / Cellid
NCT05520970: Safety and Immunogenicity of COVID-19 Vaccine, AdCLD-CoV19-1

Terminated
2b
4
RoW
AdCLD-CoV19-1
Cellid Co., Ltd., International Vaccine Institute
COVID-19, Vaccines
11/22
11/22
NCT04666012: Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers

Completed
2a
150
RoW
AdCLD-CoV19
Cellid Co., Ltd.
COVID-19
07/21
03/23
NCT05047692: Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers

Completed
1
40
RoW
AdCLD-CoV19-1
Cellid Co., Ltd.
Covid19
12/22
06/23

Download Options